Comment on Rivas et al. Unexpectedly Low Rate of Metastasis and Death Among Patients Treated for Uveal Melanoma with Brachytherapy, Vitrectomy, and Silicone Oil. Cancers 2025, 17, 2683

Key Points

• The comment addresses concerns over claims of low metastasis and death rates from a uveal melanoma study.
• Review of existing clinical studies on uveal melanoma treatments.
• Analysis of findings reported by Rivas et al.
• Engagement with executive leadership of the Collaborative Ocular Oncology Group.
• Concerns raised about the credibility of the data presented by Rivas et al.
• Emphasis on the need for further validation of treatment efficacy.
• Call for continued research and discussion within the oncology community.

Abstract